华纳药厂 Stock: price and insider trades · China
华纳药厂: what insiders have been doing
华纳药厂 is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). 华纳药厂 has had no insider filing for more than a year; the last one goes back to 15 December 2022.
Over the whole record (from 2022), the tally stands at no purchases and 2 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About 华纳药厂
华纳药厂 is a company in the health and pharmaceutical sector, listed on the XSHG market. It specializes in the research and development of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
